Diversified Trust Co Buys 33,970 Shares of Ventas, Inc. $VTR

Diversified Trust Co raised its stake in Ventas, Inc. (NYSE:VTR) by 828.7% during the third quarter, HoldingsChannel reports. The fund owned 38,069 shares of the real estate investment trust’s stock after buying an additional 33,970 shares during the period. Diversified Trust Co’s holdings in Ventas were worth $2,664,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of VTR. Ameritas Advisory Services LLC bought a new position in Ventas in the 2nd quarter worth about $33,000. Golden State Wealth Management LLC raised its holdings in Ventas by 52.7% in the second quarter. Golden State Wealth Management LLC now owns 536 shares of the real estate investment trust’s stock worth $34,000 after buying an additional 185 shares during the last quarter. Elevation Point Wealth Partners LLC bought a new position in shares of Ventas in the second quarter worth approximately $35,000. IFP Advisors Inc lifted its stake in shares of Ventas by 61.3% in the second quarter. IFP Advisors Inc now owns 974 shares of the real estate investment trust’s stock worth $62,000 after buying an additional 370 shares in the last quarter. Finally, CYBER HORNET ETFs LLC purchased a new stake in shares of Ventas during the second quarter valued at approximately $67,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Performance

Shares of VTR opened at $78.86 on Wednesday. The firm has a market capitalization of $37.04 billion, a P/E ratio of 151.65, a PEG ratio of 2.01 and a beta of 0.78. The company has a debt-to-equity ratio of 1.01, a current ratio of 0.32 and a quick ratio of 0.32. Ventas, Inc. has a one year low of $56.68 and a one year high of $81.89. The business has a fifty day moving average of $77.45 and a 200 day moving average of $70.67.

Ventas (NYSE:VTR) last posted its earnings results on Wednesday, October 29th. The real estate investment trust reported $0.88 earnings per share for the quarter, beating analysts’ consensus estimates of $0.87 by $0.01. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.44 billion. Ventas had a return on equity of 2.05% and a net margin of 4.28%.Ventas’s revenue was up 20.5% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.80 earnings per share. Ventas has set its FY 2025 guidance at 3.450-3.480 EPS. As a group, sell-side analysts anticipate that Ventas, Inc. will post 3.4 EPS for the current year.

Ventas Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, January 15th. Investors of record on Wednesday, December 31st will be given a dividend of $0.48 per share. This represents a $1.92 annualized dividend and a yield of 2.4%. The ex-dividend date is Wednesday, December 31st. Ventas’s payout ratio is 369.23%.

Analyst Upgrades and Downgrades

VTR has been the subject of a number of recent analyst reports. Wells Fargo & Company boosted their price objective on shares of Ventas from $80.00 to $88.00 and gave the stock an “overweight” rating in a report on Tuesday, November 25th. Scotiabank boosted their price target on Ventas from $74.00 to $80.00 and gave the stock a “sector perform” rating in a research note on Thursday, November 13th. KeyCorp upped their price target on Ventas from $70.00 to $85.00 and gave the company an “overweight” rating in a report on Thursday, December 4th. Citigroup increased their price objective on Ventas from $80.00 to $88.00 and gave the company a “buy” rating in a research report on Tuesday, November 11th. Finally, Evercore ISI boosted their target price on Ventas from $77.00 to $80.00 and gave the stock an “outperform” rating in a research report on Monday, September 15th. One analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $79.31.

Insider Activity at Ventas

In other Ventas news, CFO Robert F. Probst sold 33,591 shares of the company’s stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $76.77, for a total transaction of $2,578,781.07. Following the completion of the sale, the chief financial officer directly owned 168,364 shares of the company’s stock, valued at approximately $12,925,304.28. This represents a 16.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Debra A. Cafaro sold 41,294 shares of Ventas stock in a transaction on Monday, November 17th. The stock was sold at an average price of $79.01, for a total transaction of $3,262,638.94. Following the transaction, the chief executive officer owned 1,145,695 shares in the company, valued at $90,521,361.95. This represents a 3.48% decrease in their position. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 673,268 shares of company stock worth $49,679,007. 1.00% of the stock is owned by company insiders.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.